Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 8/20 | 0.71 |
| ▸ | DDB1 | Q16531 | 6/20 | 0.71 |
| ▸ | HDAC1 | Q13547 | 7/20 | 0.67 |
| ▸ | HDAC6 | Q9UBN7 | 7/20 | 0.67 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.65 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.65 |
| ▸ | STAT3 | P40763 | 2/20 | 0.62 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.61 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | SNCA | P37840 | 1/20 | 0.60 |
| ▸ | PIP4K2C | Q8TBX8 | 3/20 | 0.60 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.54 |
| ▸ | BRD4 | O60885 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29622184 | 1.00 | CRBN (0.71) | CRBNDDB1HDAC1HDAC6HDAC3 | |
| SCHEMBL23768526 | 0.99 | CRBN (0.70) | CRBNDDB1HDAC1HDAC6HDAC3 | |
| SCHEMBL21062840 | 0.99 | CRBN (0.70) | CRBNDDB1HDAC1HDAC6HDAC3 | |
| SCHEMBL29622447 | 0.99 | CRBN (0.70) | CRBNDDB1HDAC1HDAC6HDAC3 | |
| SCHEMBL24376521 | 0.99 | CRBN (0.70) | CRBNDDB1HDAC1HDAC6HDAC3 | |
| SCHEMBL29622239 | 0.99 | CRBN (0.70) | CRBNDDB1HDAC1HDAC6HDAC3 | |
| SCHEMBL26317544 | 0.95 | CRBN (0.73) | CRBNDDB1HDAC1HDAC6HDAC3 | |
| SCHEMBL25036554 | 0.94 | CRBN (0.69) | CRBNDDB1HDAC1HDAC6HDAC3 | |
| SCHEMBL26917739 | 0.94 | CRBN (0.68) | CRBNDDB1HDAC1HDAC6HDAC3 | |
| SCHEMBL26319140 | 0.94 | CRBN (0.72) | CRBNDDB1HDAC1HDAC6HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024026256-A1 | SUBSTITUTED IMIDAZOPYRAZINE COMPOUNDS AS LIGAND DIRECTED DEGRADERS OF IRAK3 | CELGENE CORPORATION (US) | 2024-02-01 | — | — | WO | disclosed |
| WO-2022086937-A9 | HETEROBIFUNCTIONAL COMPOUNDS AS DEGRADERS OF ENL | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2023-02-02 | — | — | WO | disclosed |
| WO-2022086937-A1 | HETEROBIFUNCTIONAL COMPOUNDS AS DEGRADERS OF ENL | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2022-04-28 | — | — | WO | disclosed |